# Type V DMF Auto-Generation Specification
**FDA Drug Master File (DMF) Type V: Facility Information**

**Status:** MVP Feature (Phase 2d, Weeks 10–11)  
**Owner:** Build Team (with Bobby BIG validation)  
**Deliverable:** Phase 2d Friday Gate (Week 11)

---

## WHAT IS TYPE V DMF?

**Type V Drug Master File (Facility Information):**
- Comprehensive facility-specific information
- Submitted to FDA during PreCheck Pilot Program
- Referenced in drug applications by any manufacturer
- Allows facility info to be shared without repetition

**Customer Journey with GxP Planner:**
1. Build facility design (equipment spec + layout)
2. Validate facility (URS/FRS/IQ/OQ/PQ)
3. **GxP Planner generates Type V DMF (auto, ONE CLICK)**
4. Customer submits to FDA PreCheck
5. FDA reviews + provides early feedback

---

## TYPE V DMF STRUCTURE (Auto-Populated by GxP Planner)

### I. FACILITY DESCRIPTION

**Data Source:** Layout Design Module + Equipment Spec Module

```
I.1 Facility Location
   Address: [from facility setup]
   Coordinates: [optional GPS]
   Size: [total sq ft from layout]
   
I.2 Facility Type
   [ ] QC/Analytical Lab
   [ ] Small Molecule Manufacturing
   [ ] Biologics Manufacturing
   [ ] Sterile Products (Aseptic)
   [ ] Sterile Products (Terminal Sterilization)
   
I.3 Site Operations Layout
   [Auto-generated from Layout Design module]
   - Production areas: [list with ISO classification]
   - Support areas: [list with function]
   - QC lab: [location, environmental controls]
   - Warehouse: [raw material, packaging, finished goods]
   - Personnel facilities: [gowning areas, rest areas]
   
I.4 Cleanroom Classification (if applicable)
   [Auto-generated from Layout Design module]
   - ISO Class 5: [location, equipment, air changes/hr]
   - ISO Class 7: [location, equipment, air changes/hr]
   - ISO Class 8: [location, equipment, air changes/hr]
   - Non-cleanroom: [location, environmental controls]
```

### II. EQUIPMENT & UTILITIES

**Data Source:** Equipment Spec Module + Layout Design Module

```
II.1 Manufacturing Equipment
   [Auto-generated from Equipment Spec module]
   - Equipment Name: [e.g., HPLC System A]
   - Manufacturer: [Shimadzu, Waters, Agilent, etc.]
   - Model: [LC-2030 Plus]
   - Serial Number: [123456789]
   - Location: [Room 2.1 – QC Lab]
   - Qualification Status: [IQ Complete | OQ In Progress | PQ Complete]
   - Critical Parameters: [Flow rate 1.0 mL/min ±5%, Pressure 400 bar max, etc.]
   - Lead Time: [10 weeks from order]
   
II.2 Utility Systems
   [Auto-generated from Layout Design module]
   - Water System (PW/WFI):
     * Type: [Distillation | Reverse Osmosis | Hybrid]
     * Validation Status: [Complete | In Progress]
     * Storage: [Holding tank 500L, temperature 60–65°C]
   - Compressed Air:
     * Quality: [Instrument | Process | General]
     * Filtration: [Particulate + Oil removal]
   - HVAC System:
     * Type: [Modular | Central]
     * Air Changes: [20/hr (ISO 5), 15/hr (ISO 7), 12/hr (ISO 8)]
     * Filter: [HEPA H14, 99.995% @ 0.3µm]
     * Pressure Control: [+10 Pa to +50 Pa (ISO 5)]
   - Waste System:
     * Type: [Non-contact drainage | Contact drainage with treatment]
     * Segregation: [Pharmaceutical waste separate from general waste]
```

### III. PHARMACEUTICAL QUALITY SYSTEM (PQS)

**Data Source:** Risk Management Module + Validation Lifecycle Module

```
III.1 Quality Objectives
   [Auto-populated from Risk Management module]
   - Ensure product safety and efficacy
   - Prevent contamination (microbial, particulate, chemical)
   - Maintain data integrity per 21 CFR Part 11
   - Achieve consistency across all batches
   
III.2 Management Responsibility
   [From Team Management, Wave 2 - or manual input Week 10]
   - Quality Assurance Director: [Name]
   - Quality Control Manager: [Name]
   - Manufacturing Manager: [Name]
   - Facility Manager: [Name]
   
III.3 Resource Management
   [Auto-generated from Validation Lifecycle + Training modules]
   - Personnel Training: [All operators trained in GMP]
   - Documentation: [SOPs drafted, in review]
   - Equipment: [All critical equipment qualified or in qualification]
   
III.4 Product Realization (Process Design & Validation)
   [Auto-generated from Validation Lifecycle module]
   - Design Phase: [URS v1.0 approved, FRS v1.0 approved]
   - Design Specification: [DS approved]
   - Validation Approach: [IQ/OQ/PQ planned]
   - Current Status: [IQ 100%, OQ 75%, PQ planned Week 15]
   
III.5 Measurement, Analysis, Improvement
   [Auto-generated from Compliance Dashboard + Risk Module]
   - Environmental Monitoring: [Daily for ISO 5, weekly for ISO 7/8]
   - In-Process Controls: [Defined per process]
   - CAPA Process: [Defined in SOP]
   - Risk Management: [ICH Q9 framework implemented]
```

### IV. QUALITY MANAGEMENT MATURITY (QMM) PRACTICES

**Data Source:** Risk Management Module + Compliance Dashboard

```
IV.1 Quality Management Maturity Assessment
   [Auto-scored from Compliance Dashboard]
   
   Maturity Level 1 (Basic):
      [ ] Quality objectives defined
      [ ] GMP requirements understood
      [ ] Documentation requirements met
      
   Maturity Level 2 (Structured):
      [ ] Risk management framework (ICH Q9) implemented
      [ ] Quality system documentation complete
      [ ] Training program established
      
   Maturity Level 3 (Integrated):
      [ ] Quality by Design (ICH Q8) integrated into product/process
      [ ] Continuous improvement program active
      [ ] Data integrity controls per 21 CFR Part 11
      
   Maturity Level 4 (Optimized):
      [ ] Predictive analytics for process optimization
      [ ] Advanced quality controls (real-time data)
      [ ] Zero-defect culture established
   
   Current Assessment: [Level 2 or 3 - auto-calculated from validation status]
   
IV.2 Continuous Improvement Examples
   [Auto-generated from Risk Mitigation Tracking]
   - Risk identified: [Microbial contamination risk in ISO 5]
   - Mitigation implemented: [HEPA filtration + environmental monitoring]
   - Verification: [Environmental baseline established, 0 CFU detected]
   
IV.3 Data Integrity & Security
   [Auto-generated from Compliance Dashboard]
   - 21 CFR Part 11 compliant: [YES]
   - Audit trail implemented: [YES]
   - User access controls: [YES]
   - Electronic records retention: [7 years minimum]
```

### V. VALIDATION & TESTING

**Data Source:** Validation Lifecycle Module + Test Suite

```
V.1 Validation Master Plan
   [Auto-generated from Validation Lifecycle module]
   - Scope: [List of equipment + systems to be validated]
   - Approach: [IQ/OQ/PQ for each equipment type]
   - Timeline: [URS Week 1–2, FRS Week 3–4, IQ Week 9–10, OQ Week 11–12, PQ Week 13–14]
   - Responsibilities: [Build Team, QA Team, Validation Lead]
   - Success Criteria: [All IQ/OQ/PQ tests passing, coverage ≥88%]
   
V.2 Installation Qualification (IQ)
   [Auto-generated from IQ Test Results]
   - Equipment: [HPLC System A]
   - Installation Certificate: [Attached]
   - Calibration Certificate: [Attached]
   - Functional Checks: [All passed]
   - Status: [Complete | In Progress | Not Started]
   
V.3 Operational Qualification (OQ)
   [Auto-generated from OQ Test Results]
   - Equipment: [HPLC System A]
   - Performance Tests: [Flow rate verification, pressure range, detector response]
   - Acceptance Criteria: [Flow rate 1.0 ±0.05 mL/min]
   - Results: [All tests PASS]
   - Status: [Complete | In Progress | Not Started]
   
V.4 Performance Qualification (PQ)
   [Auto-generated from PQ Test Results]
   - Equipment: [HPLC System A]
   - Test Batches: [3 consecutive batches per USP <1225>]
   - Acceptance Criteria: [RSD ≤2% across 3 batches]
   - Results: [Batch 1: RSD 1.2% PASS | Batch 2: RSD 1.4% PASS | Batch 3: RSD 1.1% PASS]
   - Status: [Complete | In Progress | Not Started]
   
V.5 Environmental Monitoring (if sterile product)
   [Auto-generated from Environmental Monitoring logs]
   - Air Particulate Monitoring:
     * Location: [ISO 5 area, critical operation]
     * Frequency: [Continuous during operations]
     * Baseline: [100 particles <0.5µm per m³ at rest]
     * Action Level: [>300 particles]
     * Data: [30-day average: 85 particles]
   - Microbial Monitoring:
     * Location: [ISO 5 area]
     * Frequency: [Daily plate exposure during operations]
     * Baseline: [0 CFU detected in 30 days]
     * Action Level: [>1 CFU]
     * Data: [30-day baseline complete, 0 CFU detected]
   - Surface Monitoring:
     * Location: [ISO 5 equipment surfaces]
     * Frequency: [Weekly]
     * Acceptance: [<100 CFU per plate]
     * Data: [5 surfaces tested, all <100 CFU]
   
V.6 Analytical Method Validation (QC Lab)
   [Auto-linked from Wave 2 LIMS Integration or manual entry]
   - Method: [HPLC for [Drug Substance] assay]
   - USP Reference: [<1225> Validation of Compendial Procedures]
   - Validation Parameters: [Specificity, Linearity, Accuracy, Precision, Range]
   - Status: [Planned | In Progress | Complete]
```

### VI. PERSONNEL TRAINING & COMPETENCY

**Data Source:** Training Module (Wave 2) or Bobby's manual curation

```
VI.1 Personnel Training Records
   [Auto-generated from Training module, if available in Wave 2]
   - Operator Name: [John Smith]
   - Position: [QC Analyst]
   - GMP Certification: [Yes, expires 2027-03-15]
   - Equipment Training: [HPLC System A - Completed 2026-01-10]
   - Method Training: [Assay method XYZ - Completed 2026-02-15]
   - Status: [Qualified to operate]
   
VI.2 Training Program
   [Manual entry Week 10]
   - Initial Training: [GMP fundamentals, equipment-specific, method-specific]
   - Refresher Training: [Annual, with competency assessment]
   - Records Retention: [7 years minimum]
```

### VII. CHANGE HISTORY & CHANGE CONTROL

**Data Source:** Change Control Log (Wave 2) or Bobby's curation

```
VII.1 Significant Changes to Facility or Equipment
   [Auto-generated from Change Control module, if available in Wave 2]
   - Change: [Replace HPLC detector with newer model]
   - Date: [2026-02-15]
   - Reason: [Improved sensitivity, vendor support extended]
   - Impact Assessment: [Requires IQ/OQ validation]
   - Approval: [Bobby BIG, Regulatory]
   - Status: [Approved, IQ/OQ in progress]
   
VII.2 Change Control Process
   [Manual curation Week 10]
   - Submission: [Description, reason, impact]
   - Review: [Regulatory review + Quality approval]
   - Approval: [Sign-off by Quality Unit]
   - Implementation: [Tracked in Change Control log]
   - Verification: [Change validated per plan]
```

---

## PHASE 2D IMPLEMENTATION (Weeks 10–11)

### Week 10: Type V DMF Generation Engine Built

**Build Task:**
- [ ] Connect Equipment Spec module → Section II (Equipment & Utilities)
- [ ] Connect Layout Design module → Section I (Facility Description)
- [ ] Connect Validation Lifecycle module → Section V (Validation & Testing)
- [ ] Connect Risk Management module → Section III.1 (Quality Objectives) + Section IV (QMM)
- [ ] Connect Compliance Dashboard → Section IV (QMM Assessment)
- [ ] Create manual input forms for Sections III.2 (Management), VI (Training)

**QA Task:**
- [ ] Test: Generate Type V DMF from sample facility (3 test scenarios)
- [ ] Verify: All sections populate correctly
- [ ] Validate: Format matches FDA DMF template

**Bobby Reviews:**
- [ ] Does generated DMF match FDA expectations?
- [ ] Are all sections complete + approvable?
- [ ] Any adjustments needed before customer submission?

### Week 11: Type V DMF Wizard + Testing

**Build Task:**
- [ ] Create "Generate Type V DMF" button (one-click generation)
- [ ] Create "Review DMF" page (customer sees generated content)
- [ ] Create "Download DMF" option (PDF + Word doc)
- [ ] Create "Submit to FDA" guidance (instructions for PreCheck submission)

**QA Task:**
- [ ] Test: One-click generation works end-to-end
- [ ] Test: PDF/Word formatting correct
- [ ] Test: Generated DMF readable + editable by customer

**Bobby Validates:**
- [ ] Would you submit this DMF to FDA as-is? Yes/No
- [ ] Any customer guidance needed?
- [ ] Final sign-off: "Type V DMF ready for PreCheck"

---

## FRIDAY GATE CHECKPOINT (Week 11)

**Build Team Presents:**
- Type V DMF auto-generation engine complete
- 100% of test scenarios passing
- Customer can generate DMF in <1 minute
- Customer can download PDF/Word format

**Bobby Reviews (as Compliance Expert):**
- Does generated DMF cover all FDA requirements?
- Is format approvable for PreCheck submission?
- Would you feel confident submitting this to FDA?

**Decision:**
- ✅ Proceed to Phase 3 (final integration)
- ⚠️ Conditional: Minor edits needed (specify)
- ❌ Blocked: Major rework required (specify)

---

## COMPETITIVE ADVANTAGE

**GxP Planner = PreCheck Submission Generator**

**Customer Flow:**
1. Build facility (equipment + layout)
2. Validate facility (URS/FRS/IQ/OQ/PQ)
3. **Click: Generate Type V DMF** ← THIS IS THE MOAT
4. Submit to FDA PreCheck
5. FDA approves facility design early
6. Proceed to construction + validation with FDA alignment

**Competitors:**
- Manual DMF assembly (8+ hours of consulting)
- Consultant-written DMF (risk of inaccuracy)
- No real-time validation

**GxP Planner:**
- Auto-generated DMF (validated by Bobby's 30 years expertise)
- One-click submission (no consultant needed)
- Pre-validated by FDA-aligned system

**Pricing Impact:**
- Standalone GxP: $2K–$6K/month
- + Type V DMF auto-generation: Worth $5K–$15K premium to customers (saves consultant fees)
- New positioning: "DMF-included SaaS" (higher value, higher price)

---

## WHAT BOBBY NEEDS TO VALIDATE (Week 10–11)

1. **Section I (Facility Description):** Does layout module output sufficient detail for FDA?
2. **Section II (Equipment & Utilities):** Are all critical parameters captured?
3. **Section III (PQS):** Do quality objectives/management/resources look complete?
4. **Section IV (QMM):** Does maturity scoring reflect actual facility status?
5. **Section V (Validation & Testing):** Do test results accurately map to DMF sections?
6. **Section VI (Personnel):** Is training documentation sufficient for FDA?
7. **Section VII (Change History):** Would FDA find this change control adequate?

**If all 7 sections validated: "Type V DMF generation is FDA-approvable"**

---

## RISK MITIGATION (Bobby's 30 Years = Safety Net)

**Risk:** "Type V DMF format is wrong, customer's PreCheck submission rejected"

**Mitigation:**
- Bobby validates format against FDA expectations (Week 10–11)
- Bobby can adjust format before launch if needed
- System tested with real facility scenario (Bobby-approved)
- Customer guidance provided (how to edit/submit)

**Result:** Extremely low risk. Bobby's expertise ensures FDA-approvability.

---

## BOTTOM LINE

**Type V DMF auto-generation in MVP = Customer killer feature.**

Customers use GxP Planner not just for planning, but for PreCheck submission preparation. This is the moat competitors can't replicate without understanding FDA PreCheck deeply.

With Bobby's validation from Week 10–11, confidence is high that generated DMF will be approvable by FDA.

June 11 delivery: **90% confidence** (up from 75%).

